Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • RTM
    Junior Member
    • Oct 2013
    • 7

    #1

    Variant calling on matched primary and metastatic tumor without normal samples.

    Hello!

    I have exome sequencing data for 20 pairs of primary and matched metastatic tumors coming different patients. However, I have no Normal samples.

    I am interested in looking at mutation evolution from the primary to metastatic samples. What would be the best strategy to call variants? The way I see it, I have two options:

    1) Call variants using the primary sample as the control sample for their matched metastatic sample and use the metastatic sample as the normal for the primary sample.

    2) Follow the TCGA workflow for Tumor-Only variant calling and just call the samples independently. https://docs.gdc.cancer.gov/Data/Bio...ation-workflow

    3) Would it make more sense to create a "Panel of Normals" for each patient using the matched primary and metastatic tumor?

    I would like to hear your thoughts on how to approach this problem. thank you all in advance for the advice!!!

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...